[1]翟思田,王志刚△,周澎.芪甲通淋化瘀方治疗前列腺增生症30例[J].西部中医药,2019,32(06):78-80.
　ZHAI Sitian,WANG Zhigang,ZHOU Peng.Treating 30 Cases of Benign Prostatic Hyperplasia by Qijia Tonglin Huayu Prescription[J].Western Journal of Traditional Chinese Medicine,2019,32(06):78-80.
点击复制

芪甲通淋化瘀方治疗前列腺增生症30例
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年06期
页码:
78-80
栏目:
出版日期:
2019-06-15

文章信息/Info

Title:
Treating 30 Cases of Benign Prostatic Hyperplasia by Qijia Tonglin Huayu Prescription
文章编号:
1004-6852(2019)06-0078-03
作者:
翟思田，王志刚△，周澎
天水市中医医院，甘肃 天水741000
Author(s):
ZHAI Sitian, WANG Zhigang△, ZHOU Peng
Tianshui Hospital of TCM, Tianshui 741000, China
关键词:
前列腺增生症; 芪甲通淋化瘀方; 国际前列腺症状评分
Keywords:
prostatic hyperplasia;  Qijia Tonglin Huayu prescription;  international prostate symptom score
分类号:
R697+.3
文献标志码:
B
摘要:
目的:观察芪甲通淋化瘀方治疗前列腺增生症(BPH）的临床疗效。方法：将60例BPH患者随机分为2组，每组30例。对照组予以非那雄胺口服，5 mg/次，1次/d。观察组以芪甲通淋化瘀方为基础方进行辨证治疗，每日1剂，水煎早晚分服。2组均以连续用药1个月为1个疗程，连续治疗2个疗程，服药期间禁烟酒。观察2组临床疗效及治疗前后国际前列腺症状（I-PSS）评分、最大尿流率(Qmax)及前列腺体积的变化情况。结果:总有效率观察组为83.3%，对照组为70.0%，2组比较差异有统计学意义（P＜0.05）。I-PSS评分、Qmax、前列腺体积治疗前后2组组内比较，差异有统计学意义(P＜0.05)；治疗后组间比较差异也有统计学意义(P＜0.05)。结论：芪甲通淋化瘀方治疗BPH可以显著改善临床症状，增加最大尿流量，缩小前列腺体积。
Abstract:
Objective: To observe clinical effects of Qijia Tonglin Huayu prescription in the treatment for benign prostatic hyperplasia (BPH). Methods: Sixty BPH patients were randomized into two groups, 30 cases each group. The control group took finasteride orally, 5 mg each time, once each day. The observation group were treated by syndrome differentiation and taking Qijia Tonglin Huayu prescription as the basic prescription, one dose each day, water decocted and taking in the morning and evening. Both groups were treated for one month as one course, for two course consecutively, no smoking and alcohol during the medication period. To observe clinical effects, I-PSS scores before and after treating, Qmax and the changes of prostate volume between both groups. Results: Total effective rate of the observation group was 83.3%, higher than 70.0% of the control group, and the difference had statistical meaning (P＜0.05). The difference showed statistical meaning in the comparisons of I-PSS scores, Qmax and prostate volume within two groups before and after treating (P＜0.05); the difference had statistical meaning in the comparisons between both groups after treating (P＜0.05). Conclusion: Qijia Tonglin Huayu prescription in the treatment for BPH could notably improve clinical symptoms, increase Qmax and reduce prostate volume.

相似文献/References:

[1]刘万彪.中西药物联合治疗老年良性前列腺增生症80例[J].西部中医药,2013,26(06):93.
　LIU Wanbiao.Combination of Western Medicine and Traditional Chinese Medicine for 80 Senile Patients with Benign Prostatic Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2013,26(06):93.
[2]贾天鹏.穴位埋线治疗前列腺增生症41例[J].西部中医药,2014,27(04):112.
　JIA Tianpeng.Catgut Implantation at Acupoint in Treating 41 Cases of Prostatic Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2014,27(06):112.
[3]张春晓,张永臣.近10年针灸治疗前列腺增生症的临床研究概况[J].西部中医药,2013,26(07):127.
　ZHANG Chunxiao,ZHANG Yongchen.Clinical Study of Acupuncture in Treating Prostatic Hyperplasia in Recent Ten Years[J].Western Journal of Traditional Chinese Medicine,2013,26(06):127.
[4]杨楠.经尿道等离子前列腺电切术配合猪苓汤口服治疗前列腺增生症疗效观察[J].西部中医药,2018,31(05):110.
　YANG Nan.Observation on Clinical Effects of Transuretheral Resection of the Prostate Combined with Oral Administration of ZhuLing Decoction in the Treatment for Benign Prostatic Hyperplasia[J].Western Journal of Traditional Chinese Medicine,2018,31(06):110.

备注/Memo

备注/Memo:
收稿日期：2018-12-20作者简介：翟思田(1967—)，男，副主任医师。研究方向：神经外科及急诊外科疾病的诊治。△通讯作者：王志刚(1965—)，男，硕士研究生导师，主任医师，甘肃省名中医，全国第六批老中医药专家学术经验继承工作指导老师，享受国务院政府特殊津贴专家。中国中医药研究促进会常委；中国中医药研究促进会内分泌分会副会长；甘肃省医学会糖尿病专业委员会委员；甘肃省内分泌代谢委员会委员；甘肃省中西医结合学会常务理事；甘肃省中西医结合糖尿病专业委员会副主任委员；甘肃省中医糖尿病专业委员会副主任委员；
更新日期/Last Update: 2019-06-15